Phase I Trial of IDL-2965 in Healthy Volunteers and IPF patients

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  253853

• Contact name

  Jim Bush

• Contact email

  Jim.Bush@covance.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2019-000173-23

• Clinicaltrials.gov Identifier

  19/NW/0001, GM Central

• Duration of Study in the UK

  1 years, 1 months, 27 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  19/NW/0001

• Date of REC Opinion

  25 Feb 2019

• REC opinion

  Favourable Opinion